Avadel Pharmaceuticals plc announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 30, 2023, to provide a corporate update and discuss the Company’s financial results for the fourth quarter and full year ended December 31, 2022.
Delcath Systems, Inc. announces that it has closed its previously announced private placement, for gross proceeds of approximately $25.0 million from the issuance and sale of shares of the Company’s common stock and shares of its Series F Convertible Preferred Stock and warrants, before deducting the fees paid to the placement agent and the financial
Delcath Systems Announces Closing of Private Placement of up to $85 Million Read More »
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced the pricing of its underwritten public offering of 17,242,000 shares of its common stock at a price to the public of $14.50 per share.
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock Read More »
There have already been several big biotech licensing deals in Q1. See inside for some of this quarter’s biggest licensing deals — from the surprising and pivotal to the lucrative and consequential.
Insurance and provider lobbies called on the CMS to delay the rule earlier this month, saying the methodology was flawed and arguing the 30-day comment period didn’t give them enough time to analyze the proposed changes.
Warren calls on CMS to finalize MA payment change Read More »
Citing reports of “alarming toxicity” among other accusations, short-seller Scorpion Capital will file a Citizen’s Petition with the FDA to have its approval of Wakix withdrawn.
Scorpion Stings Harmony with Citizen’s Petition Threat for Sleepiness Drug Read More »
Boston-based Covant Therapeutics gained $10 million upfront in a deal with Boehringer Ingelheim to chase after a cancer immunotherapy target, ADAR1.
Covant Therapeutics Debuts with Boehringer Partnership Targeting ADAR1 Read More »
Amazon Pharmacy is currently offering coupons for eight brand name medications treating diabetes, asthma, obesity, emphysema and others, and said it plans to add more coupons over time.
Amazon Pharmacy adds manufacturer coupons for some brand name drugs Read More »
The company, which reported a net loss on Tuesday, is also exploring strategic alternatives for its Xoft therapy business.
Breast cancer AI company iCAD lays off workers, names new CEO Read More »
The FDA could decline premarket submissions that lack adequate cybersecurity information.
Device cybersecurity enforcement delayed to October: FDA Read More »
